高级检索
当前位置: 首页 > 详情页

Vinculin and filamin-C are two potential prognostic biomarkers and therapeutic targets for prostate cancer cell migration.

文献详情

资源类型:
Pubmed体系:
机构: [1]Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China [2]Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China [3]Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China [4]Animal Experimental Center, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. Ch
出处:

摘要:
Prostate cancer (PCa) is one of the most common diseases for male population, and the effective treatment for metastatic castration-resistant PCa is still lacking. To unravel the underlying mechanism of PCa cell migration, we plan to analyze the related crucial proteins and their roles. In our study, we firstly identify the differentially expressed proteins using quantitative proteomics, and confirm their mRNA expression using quantitative polymerase chain reaction (qPCR). The alterations of these proteins at DNA and mRNA levels are obtained from cBioPortal database. Furthermore, the functions of these proteins are evaluated using wound-healing assay. The quantitative proteomics identified vinculin (VCL) and filamin-C (FLNC) as two highly expressed proteins in PC3 cells, and the DNA and mRNA of these two proteins were amplified and upregulated in a part of PCa patients. Knockdown of VCL and FLNC gene expression significantly inhibit PCa cell migration. These findings suggest that VCL and FLNC identified by quantitative proteomics are highly expressed in PCa cells with high migration potential, and they could be effective targets for repressing PCa cell migration, paving a new avenue for the prognosis and treatment of advanced PCa.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学 3 区 细胞生物学
最新[2023]版:
第一作者:
第一作者机构: [1]Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China [2]Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China
共同第一作者:
通讯作者:
通讯机构: [1]Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China [2]Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号